Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice

  • Authors:
    • Wenjun Fu
    • Yuan Dai
    • Tao Ma
    • Jiangping Wei
    • Huan Chen
    • Shijun Xu
  • View Affiliations

  • Published online on: February 26, 2018     https://doi.org/10.3892/etm.2018.5897
  • Pages: 4005-4013
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Alzheimer's disease (AD) is the most common type of dementia. Amyloid‑β (Aβ)-induced neurodegeneration is hypothesized to be the primary pathological mechanism of AD. Tongluo Xingnao effervescent tablets (TXET), based on the traditional Chinese formula Qionggui Tang, have been used to treat AD and other types of dementia in China for decades. In the present study, the effects of TXET on cognition deficit, amyloid‑β production, amyloid precursor protein procession and β‑secretase expression were investigated in the APPswe/PS1dE9 mouse model of AD. As expected, APPswe/PS1dE9 mice exhibited cognitive decline and higher levels of Aβ and plaques in the brain compared with normal mice; however, these changes were attenuated following TXET treatment. Levels of C‑terminal fragment (CTF)‑β protein were decreased following treatment with TXET; however, CTF‑α levels were unaffected. Furthermore, TXET treatment did not decrease γ‑secretase activity or levels of presenilin‑1 (PS1), neprilysin or insulin‑degrading enzyme. These results indicate that TXET may regulate Aβ metabolism by downregulating the expression of β‑secretase. The results of the present study have laid the foundation for the development of a Chinese medicinal compound with a β‑secretase inhibitor as the target for the treatment of AD.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fu W, Dai Y, Ma T, Wei J, Chen H and Xu S: Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice. Exp Ther Med 15: 4005-4013, 2018.
APA
Fu, W., Dai, Y., Ma, T., Wei, J., Chen, H., & Xu, S. (2018). Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice. Experimental and Therapeutic Medicine, 15, 4005-4013. https://doi.org/10.3892/etm.2018.5897
MLA
Fu, W., Dai, Y., Ma, T., Wei, J., Chen, H., Xu, S."Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice". Experimental and Therapeutic Medicine 15.4 (2018): 4005-4013.
Chicago
Fu, W., Dai, Y., Ma, T., Wei, J., Chen, H., Xu, S."Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice". Experimental and Therapeutic Medicine 15, no. 4 (2018): 4005-4013. https://doi.org/10.3892/etm.2018.5897